✕
Login
Register
Back to News
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $70
Benzinga Newsdesk
www.benzinga.com
Positive 83.2%
Neg 0%
Neu 0%
Pos 83.2%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment